Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running.

PubWeight™: 1.51‹?› | Rank: Top 4%

🔗 View Article (PMID 1611721)

Published in Clin Immunol Immunopathol on May 01, 1992

Authors

H Sprenger1, C Jacobs, M Nain, A M Gressner, H Prinz, W Wesemann, D Gemsa

Author Affiliations

1: Institute of Immunology, Philipps University, Marburg, Germany.

Articles citing this

Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol (2000) 3.09

Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol (1998) 2.49

Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol (1999) 2.46

A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol (1998) 1.59

Effects of exercise on lymphocytes and cytokines. Br J Sports Med (2000) 1.45

Muscle-derived interleukin-6: possible biological effects. J Physiol (2001) 1.39

Effect of prolonged, submaximal exercise and carbohydrate ingestion on monocyte intracellular cytokine production in humans. J Physiol (2000) 1.21

A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clin Exp Immunol (2013) 1.03

The effect on immunity of long-term intensive training in elite swimmers. Clin Exp Immunol (1995) 1.02

Exhaustive exercise causes an anti-inflammatory effect in skeletal muscle and a pro-inflammatory effect in adipose tissue in rats. Eur J Appl Physiol (2009) 1.00

Effect of eicosapentaenoic Acid (EPA) and vitamin e on the blood levels of inflammatory markers, antioxidant enzymes, and lipid peroxidation in Iranian basketball players. Iran J Public Health (2010) 0.93

Plasma IL-6 concentration during ultra-endurance exercise. Eur J Appl Physiol (2010) 0.84

Inflammation and adipose tissue: effects of progressive load training in rats. Lipids Health Dis (2010) 0.83

Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial. PLoS One (2014) 0.82

Effects of downhill and uphill exercises of equivalent submaximal intensities on selected blood cytokine levels and blood creatine kinase activity. Biol Sport (2014) 0.81

Effects of Exhaustive Aerobic Exercise on Tryptophan-Kynurenine Metabolism in Trained Athletes. PLoS One (2016) 0.79

Short-Wave Diathermy Pretreatment and Inflammatory Myokine Response After High-Intensity Eccentric Exercise. J Athl Train (2015) 0.76

Tryptophan Metabolism in Allergic Disorders. Int Arch Allergy Immunol (2016) 0.75

Dynamic and Static Exercises Differentially Affect Plasma Cytokine Content in Elite Endurance- and Strength-Trained Athletes and Untrained Volunteers. Front Physiol (2017) 0.75

The Effect of Body Mass on the Shoe-Athlete Interaction. Appl Bionics Biomech (2017) 0.75

SELDI-TOF-MS Serum Profiling Reveals Predictors of Cardiac MRI Changes in Marathon Runners. Int J Proteomics (2012) 0.75

Serum neopterin is not increased in obese juveniles. J Obes (2011) 0.75

Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial. Nutrients (2016) 0.75

Inflammatory response to strenuous muscular exercise in man. Mediators Inflamm (1993) 0.75

Diet Versus Exercise in Weight Loss and Maintenance: Focus on Tryptophan. Int J Tryptophan Res (2016) 0.75

A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapy. Sci Rep (2016) 0.75

Articles by these authors

An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79

Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol (1982) 3.24

Combined report on regular dialysis and transplantation in Europe. X, 1979. Proc Eur Dial Transplant Assoc (1980) 3.12

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev (2001) 3.07

Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol (1988) 2.58

Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett (2001) 2.46

The phosphorylation of liver ribosomal proteins in vivo. Evidence that only a single small subunit protein (S6) is phosphorylated. J Biol Chem (1974) 2.40

Combined Report on Regular Dialysis and Transplantation in Europe, IX, 1978. Proc Eur Dial Transplant Assoc (1979) 2.27

The kinetic mechanism of Ran--nucleotide exchange catalyzed by RCC1. Biochemistry (1995) 2.20

cAPK-phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin-S2 in an on-off fashion. FEBS Lett (1999) 2.16

Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterol Motil (2015) 2.12

Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00

Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology (1994) 1.98

Kinetic analysis by fluorescence of the interaction between Ras and the catalytic domain of the guanine nucleotide exchange factor Cdc25Mm. Biochemistry (1998) 1.97

Combined report on regular dialysis and transplantation in Europe, XIII, 1982. Proc Eur Dial Transplant Assoc (1983) 1.97

Practical implications of coexistent different technologies in clinical chemical laboratories. Solid phase chemistry and conventional analysis. Eur J Clin Chem Clin Biochem (1991) 1.96

Expression of pp60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas. Cancer Res (1983) 1.88

Combined report on regular dialysis and transplantation in Europe, VIII, 1977. Proc Eur Dial Transplant Assoc (1978) 1.85

Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology (2000) 1.84

The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology (1987) 1.84

Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron (1982) 1.76

The protein component of scrapie-associated fibrils is a glycosylated low molecular weight protein. EMBO J (1985) 1.76

Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J Pathol (2005) 1.73

Combined Report on Regular Dialysis and Transplantation of Children in Europe, 1978. Proc Eur Dial Transplant Assoc (1979) 1.73

The visual display of regulatory information and networks. Trends Cell Biol (2000) 1.70

Mortality and morbidity of reusing dialysers. A report by the registration committee of the European Dialysis and Transplant Association. Br Med J (1978) 1.70

Combined report on regular dialysis and transplantation in Europe, XI, 1980. Proc Eur Dial Transplant Assoc (1981) 1.68

Long-term follow-up of living kidney donors: quality of life after donation. Transplantation (1999) 1.65

Combined report on regular dialysis and transplantation of children in Europe, 1977. Proc Eur Dial Transplant Assoc (1978) 1.64

Combined report on regular dialysis and transplantation in Europe, VII, 1976. Proc Eur Dial Transplant Assoc (1977) 1.63

Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest (1992) 1.62

The childhood experience of care and abuse questionnaire (CECA.Q): validation in a community series. Br J Clin Psychol (2005) 1.59

Influence of ABO blood groups on primary hemostasis. Transfusion (2001) 1.59

Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha. J Immunol (1988) 1.53

Idiopathic acute interstitial nephritis associated with anterior uveitis in adults. Clin Nephrol (1989) 1.53

Kinetics of the transformation of Gram-negative rods to spheroplasts and ghosts by serum. J Immunol (1966) 1.51

Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukoc Biol (1997) 1.51

Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51

Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radic Biol Med (2001) 1.48

Novel genes coding for lithotrophic sulfur oxidation of Paracoccus pantotrophus GB17. J Bacteriol (2000) 1.47

Modification of cisplatin toxicity with diethyldithiocarbamate. J Clin Oncol (1990) 1.46

Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation. J Biol Chem (2000) 1.42

Renal tolerance for ioxaglate in patients with chronic renal failure. Radiology (1991) 1.42

Transplantation of CD34+ hematopoietic progenitor cells. Cancer Invest (1996) 1.40

Renal tolerance of nonionic dimers. Invest Radiol (1996) 1.40

Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. J Immunol (1991) 1.39

[The clinical value of laminin determination in advanced liver cirrhosis]. Dtsch Med Wochenschr (1996) 1.39

Role of macrophage cytokines in influenza A virus infections. Immunobiology (1993) 1.39

Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol (1990) 1.36

Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison. Clin Chem (1997) 1.35

Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor. J Immunol (1986) 1.34

Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34

Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis (1996) 1.32

Chemokines in the cerebrospinal fluid of patients with meningitis. Clin Immunol Immunopathol (1996) 1.31

Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukoc Biol (2001) 1.30

Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol (1987) 1.30

Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology (2001) 1.29

Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology (2006) 1.28

Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. Gen Pharmacol (1997) 1.28

Spontaneous rupture of the spleen: ultrasound patterns, diagnosis and follow-up. Br J Radiol (2003) 1.27

Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes. J Immunol (1992) 1.25

Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. J Immunol (1984) 1.24

Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther (1980) 1.23

Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women. Br J Cancer (2002) 1.23

Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology (1997) 1.23

Prostaglandin synthesis in spleen cell cultures of mice injected with Corynebacterium parvum. Cell Immunol (1978) 1.20

Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood (1999) 1.20

Isolated cysticercosis of the breast masquerading as a breast tumour: report of a case and review of literature. Ann Trop Med Parasitol (2011) 1.20

Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology (1998) 1.19

Malignant diseases in patients treated by dialysis and transplantation in Europe. Transplant Proc (1981) 1.18

Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors (2005) 1.18

Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol (1982) 1.18

Correlation of optotypes with the Landolt ring--a fresh look at the comparability of optotypes. Optom Vis Sci (1994) 1.18

Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant (2001) 1.17

Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population. Cell Growth Differ (2000) 1.17

The effects of phagocytosis, dextran sulfate, and cell damage on PGE1 sensitivity and PGE1 production of macrophages. J Immunol (1978) 1.17

Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection. J Exp Med (1996) 1.17

Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial. J Clin Oncol (2001) 1.16

Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-alpha (TNF alpha) gene expression. Res Virol (1997) 1.15

Tumor necrosis factor alpha (TNF alpha) and transforming growth factor beta 1 (TGF beta 1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 1.15

Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2. J Immunol (1989) 1.13

Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. Int J Pharm (2002) 1.13

Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J Immunol (1986) 1.13

Topological studies of lactose permease of Escherichia coli by protein sequence analysis. Ann N Y Acad Sci (1985) 1.12

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12

Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study. Nephrol Dial Transplant (1996) 1.12

Behavior of cancer patients: a randomized study of the effects of education and peer support groups. Am J Clin Oncol (1983) 1.11

Influence of glucagon and cyclic adenosine 3':5'-monophosphate on the phosphorylation of rat liver ribosomal protein S6. J Biol Chem (1976) 1.11

Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus. Cell Immunol (1998) 1.11

Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells. Gut (2005) 1.11

MIF expression in the rat brain: implications for neuronal function. Mol Med (1998) 1.10